Post-earnings recap
Reported
Mon, Nov 2, 2009
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp's earnings report shows a positive surprise in EPS, which likely contributed to the stock's 4.41% increase. The absence of revenue data leaves some uncertainty, but the management's focus on efficiency suggests they are working to strengthen their financial position. Investors may view the EPS beat as a sign of resilience in a challenging market.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.69 | N/A | +5.50% |
Overall, management conveyed a positive outlook regarding their earnings performance. They highlighted their commitment to improving operational metrics.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They emphasized their focus on operational efficiency and cost management.